JHI director buys 730 shares at about $13.75

Q: What insider transaction did JHI director Kenneth J. Phelan report?

Kenneth J. Phelan reported buying 730 common shares of John Hancock Investors Trust. The transaction occurred on January 27, 2026, and was coded as a purchase, increasing his directly owned position to 730 shares after the trade.

Q: At what price were the JHI shares purchased in this Form 4 filing?

The shares were purchased at an approximate price of $13.7499 per share. The filing explains that this figure is approximate because the fund’s net asset value and related per-share price are finalized after the transaction date.

Q: How many JHI shares does Kenneth J. Phelan own after this transaction?

After the reported transaction, Kenneth J. Phelan beneficially owns 730 common shares of beneficial interest in John Hancock Investors Trust. The Form 4 indicates all of these shares are held with direct ownership following the purchase.

Q: Is the JHI Form 4 transaction by Kenneth J. Phelan a purchase or a sale?

The transaction is a purchase, shown with transaction code “P” for non-derivative securities. Phelan acquired 730 common shares of beneficial interest in John Hancock Investors Trust on January 27, 2026, rather than selling any shares.

Q: Why does the JHI Form 4 describe the transaction price as approximate?

The price is approximate because the fund’s net asset value is determined after the trade date. The filing states that the final price per share and corresponding exact number of shares could not be fully determined at the time of submission.

John Hancock Investors Trust director Kenneth J. Phelan reported buying shares in the fund.

Accepted by SEC EDGAR 01/27/2026 - 04:34 PM EST

Filing Impact

(Moderate)

Filing Sentiment

(Positive)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

John Hancock Investors Trust director Kenneth J. Phelan reported buying shares in the fund. On 01/27/2026, he purchased 730 common shares of beneficial interest in a single open-market transaction at an approximate price of $13.7499 per share, bringing his directly owned holdings to 730 shares.

The filing notes that the price and corresponding share count are approximate because the fund’s net asset value is determined after the trade date, so the exact figures were not available at the time of this report.

Insider Trade Summary

Net Buyer: 730 shares

Net Buy 1 txn

Insider Phelan Kenneth J

Role Director

Bought 730 shs ($10K)

Type	Security	Shares	Price	Value
Purchase	Common Shares of Beneficial Interest	730	$13.7499	$10K

Holdings After Transaction: Common Shares of Beneficial Interest — 730 shares (Direct)

Footnotes (1)

F1. This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did JHI director Kenneth J. Phelan report?

Kenneth J. Phelan reported buying 730 common shares of John Hancock Investors Trust. The transaction occurred on January 27, 2026, and was coded as a purchase, increasing his directly owned position to 730 shares after the trade.

At what price were the JHI shares purchased in this Form 4 filing?

The shares were purchased at an approximate price of $13.7499 per share. The filing explains that this figure is approximate because the fund’s net asset value and related per-share price are finalized after the transaction date.

How many JHI shares does Kenneth J. Phelan own after this transaction?

After the reported transaction, Kenneth J. Phelan beneficially owns 730 common shares of beneficial interest in John Hancock Investors Trust. The Form 4 indicates all of these shares are held with direct ownership following the purchase.

Is the JHI Form 4 transaction by Kenneth J. Phelan a purchase or a sale?

The transaction is a purchase, shown with transaction code “P” for non-derivative securities. Phelan acquired 730 common shares of beneficial interest in John Hancock Investors Trust on January 27, 2026, rather than selling any shares.

Does the JHI Form 4 include any derivative securities transactions?

No derivative securities transactions are reported in this Form 4. The filing’s Table II for derivative securities is empty, indicating that only a non-derivative purchase of 730 common shares of beneficial interest was disclosed for the reported date.

Why does the JHI Form 4 describe the transaction price as approximate?

The price is approximate because the fund’s net asset value is determined after the trade date. The filing states that the final price per share and corresponding exact number of shares could not be fully determined at the time of submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Phelan Kenneth J

(Last)

(First)

(Middle)

C/O JOHN HANCOCK

200 BERKELEY STREET

(Street)

BOSTON

02116

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
JOHN HANCOCK INVESTORS TRUST [ JHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares of Beneficial Interest⁽¹⁾	01/27/2026		P		730⁽¹⁾	A	$13.7499⁽¹⁾	730⁽¹⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This figure is approximate. Due to the timing of the Fund's determination of its net asset value, the price per share, and the number of shares of the Fund that corresponds to, or held as a result of, the purchase cannot be determined at the time of this filing.

	Thomas W. Dee, by Power of Attorney	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR